Exelixis Inc. buy Royal Bank of Canada
Start price
26.09.24
/
50%
€23.32
Target price
26.09.25
€24.17
Performance (%)
41.55%
End price
27.09.25
€33.01
Summary
This prediction ended on 27.09.25 with a price of €33.01. With a performance of 41.55% the BUY prediction by Royal_Bank_of_Canada was a big success. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -1.253% | -1.253% | 26.227% |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $27.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten